首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1532554

聚合酶鍊式反應 (PCR) 消耗品市場、副產品、技術、應用、最終用途 - 全球預測

Polymerase Chain Reaction (PCR) Consumables Market, By Product, Technology, Application, End-use - Global Forecast

出版日期: 2024年05月23日 | 出版商:

Global Market Insights Inc. | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在對傳染病管理的日益關注和實驗室基礎設施改善的推動下，全球聚合酶鏈反應 (PCR) 消耗品市場在 2024 年至 2032 年間將以 4.8% 的複合年成長率擴張。對 COVID-19 等傳染病進行準確、快速診斷測試的需求激增，增加了對 PCR 耗材的需求。此外，實驗室基礎設施（包括自動化和高通量系統）的進步提高了 PCR 檢測的效率和可擴展性。這些因素共同促進了 PCR 耗材的日益普及，推動了市場擴張和創新。

例如，2024 年 4 月，Eppendorf 推出了 BioBased PCR 板，增強了實驗室的永續性。 twin.tec(R) Trace 板易於自動化操作，由生物基原料製成，具有 96 個孔，並提供半透明透明版本，擴展了 Eppendorf 的產品組合。透過擴大此類創新產品的產品組合，Eppendorf 正在解決永續性問題並增強 PCR 耗材的功能和吸引力，這可能會推動市場成長並在行業中樹立新標準。

整個聚合酶鏈反應 (PCR) 耗材產業根據產品、應用、最終用途和地區進行分類。

由於製藥和生物技術公司擴大外包研發活動，到 2032 年，合約研究組織部門將佔據顯著的市場佔有率。 CRO 提供專業知識、先進技術和經濟高效的解決方案，推動了臨床試驗、藥物開發和基因研究中對 PCR 耗材的需求。為了提高效率和專注於核心能力而進行的外包趨勢不斷成長，進一步提升了 CRO 在聚合酶鍊式反應 (PCR) 耗材市場中的地位。

由於 PCR 微孔板在高通量測試和自動化領域的廣泛應用，到 2032 年，PCR 微孔板領域將經歷顯著的改善。這些微孔板有助於同時處理大量樣品，從而提高實驗室的效率和準確性。它們與各種 PCR 機器的兼容性和易用性使其在診斷、研究和臨床應用中必不可少。對快速和大規模檢測的需求不斷成長，特別是在傳染病背景下，進一步推動了 PCR 微孔板領域的突出地位。

在先進的醫療基礎設施和大量研發投資的推動下，歐洲 PCR 耗材產業將在 2024 年和 2032 年實現顯著的複合年成長率。該地區先進診斷技術的高採用率和領先生物技術公司的存在推動了市場的成長。此外，政府支持基因組研究的措施和傳染病流行率的不斷上升也增加了對 PCR 耗材的需求。歐洲對創新和卓越醫療保健的重視將使其成為全球聚合酶鍊式反應 (PCR) 耗材市場的重要貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 傳染病流行率不斷上升
  - 對分子診斷的需求不斷成長
  - 生命科學研究投資不斷增加
  - 瓣膜性心臟病的盛行率不斷增加
- 產業陷阱與挑戰
  - 監管和品質合規要求
  - 測定設計和最佳化的複雜性
成長潛力分析
技術景觀
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
PCR管
PCR 微孔板
蓋子/蓋子
其他產品

第 6 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
即時螢光定量PCR
數位PCR
傳統PCR

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
研究
臨床

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院和臨床診斷實驗室
製藥和生物技術公司
學術及研究機構
合約研究組織 (CRO)
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott Laboratories
Agilent Technologies, Inc.
Analytik Jena AG
Becton, Dickinson and Company
Bioer Technology Co., Ltd.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck KGaA
New England Biolabs, Inc.
Promega Corporation
QIAGEN N.V.
Takara Bio Inc.
Thermo Fisher Scientific, Inc.

簡介目錄

Product Code: 9609

Global Polymerase Chain Reaction (PCR) Consumables Market will expand at a 4.8% CAGR between 2024 and 2032, fueled by increased focus on infectious disease management and improved laboratory infrastructure. The surge in demand for accurate and rapid diagnostic tests for infectious diseases such as COVID-19 boosts the need for PCR consumables. Moreover, advancements in laboratory infrastructure, including automation and high-throughput systems, enhance the efficiency and scalability of PCR testing. These factors collectively contribute to the growing adoption of PCR consumables, fueling market expansion and innovation.

For instance, in April 2024, Eppendorf launched BioBased PCR Plates, enhancing laboratory sustainability. The twin.tec(R) Trace Plates, automation-friendly and made from biobased feedstock, feature 96 wells and are available in translucent clear, expanding Eppendorf's portfolio. By expanding its portfolio with such innovative products, Eppendorf is addressing sustainability concerns and enhancing the functionality and appeal of PCR consumables, which could drive market growth and set new standards in the industry.

The overall polymerase chain reaction (PCR) consumables industry is divided based on product, application, end-use, and region.

The contract research organization segment will secure a noteworthy market presence by 2032, attributed to the increasing outsourcing of research and development activities by pharmaceutical and biotechnology companies. CROs offer specialized expertise, advanced technologies, and cost-effective solutions, driving their demand for PCR consumables in clinical trials, drug development, and genetic research. The growing trend of outsourcing to enhance efficiency and focus on core competencies further boosts the prominence of CROs in the polymerase chain reaction (PCR) consumables market.

The PCR microplates segment will undergo a notable upturn by 2032 due to their widespread use in high throughput testing and automation. These microplates facilitate the simultaneous processing of numerous samples, enhancing efficiency and accuracy in laboratories. Their compatibility with various PCR machines and ease of use make them essential in diagnostic, research, and clinical applications. The growing demand for rapid and large-scale testing, particularly in the context of infectious diseases, further drives the prominence of the PCR microplates segment.

Europe PCR consumables industry will record a remarkable CAGR during 2024 and 2032, propelled by advanced healthcare infrastructure and significant investment in research and development. The region's high adoption rate of advanced diagnostic technologies and the presence of leading biotechnology companies drive market growth. Additionally, government initiatives supporting genomic research and the escalating prevalence of contagious diseases bolster demand for PCR consumables. Europe's emphasis on innovation and healthcare excellence will establish it as a vital contributor to the global polymerase chain reaction (PCR) consumables market.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of infectious diseases
  - 3.2.1.2 Growing demand for molecular diagnostics
  - 3.2.1.3 Rising investments in life sciences research
  - 3.2.1.4 Increasing prevalence of valvular heart diseases
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Regulatory and quality compliance requirements
  - 3.2.2.2 Complexity of assay design and optimization
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 PCR tubes
5.3 PCR microplates
5.4 Cap/lids
5.5 Other products

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Real time PCR
6.3 Digital PCR
6.4 Traditional PCR

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Research
7.3 Clinical

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinical diagnostic laboratories
8.3 Pharmaceutical and biotechnology companies
8.4 Academic and research institutes
8.5 Contract research organizations (CROs)
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa